IRCT20090813002342N12
Completed
Phase 3
The efficacy of intravenous phenobarbital as once or twice daily dose in neonates with seizure in NIC
Overview
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 24
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 day to 28 days (—)
- Sex
- All
Inclusion Criteria
- •Newborns with seizures that use IV phenobarbital
Exclusion Criteria
- •Neonates with liver or kidney failure
Investigators
Similar Trials
Completed
Phase 2
Effect of single dose Phenobarbital on treatment of term and near term newborn'shyper bilirubinemia admitted in the hospitalear term newborn's hyper bilirubinemia.Neonatal jaundice, unspecifiedIRCT2014102919716N4orth Khorasan University of Medical Sciences30
Active, not recruiting
Not Applicable
Plasma concentration dynamics of phenobarbital and lidocaine in neonates with seizures in hypothermiaEUCTR2010-020103-70-EEniversity of Tartu20
Completed
Phase 2
The effect of Phenobarbital on the duration of hospitalization in non-hemolytic neonatal jaundiceeonatal jaundice.Neonatal jaundice, unspecifiedIRCT2016052628090N1Qazvin University of Medical Science90
Not yet recruiting
Phase 3
Comparison of the effect of phenobarbital on the need for blood transfusion and neonatal phototherapy in mothers with IUTFetal anemia.Fetal anemia and thrombocytopenia, unspecified trimester, fetus 1O36.8291IRCT20201028049169N2Tehran University of Medical Sciences38
Not yet recruiting
Phase 3
Comparison of the effect of phenobarbital and levetiracetam in the treatment of neonatal abstinence syndromeeonatal abstinence syndrome.Neonatal withdrawal symptoms from maternal use of drugs of addictionP96.1IRCT20211218053444N2Kerman University of Medical Sciences70